HIV-positive individuals have to take their daily dose of antiretroviral medications to suppress the virus and keep it from replicating. Researchers are now experimenting with a new gel-like formula that will completely eliminate the need for taking a daily dose.
Continue reading
PrEP use during pregnancy hasn’t been studied so far. A new study provides insightful information about the safety of antiretroviral medications used to diminish the risk of contracting HIV in the event of exposure. Researchers found out that PrEP use during pregnancy is not linked to adverse outcomes.
Continue reading
Genetics play an important role in the way we respond to pathogens like the human immunodeficiency virus. A new study among people of African descent suggests that certain genetic variants supress the viral load of people who have a chronic HIV infection. These variants also reduce the risk of viral transmission.
Continue reading
The development of antiretroviral therapy (ART) is one of the most defining discoveries in the fight against HIV. New data and WHO recommendations suggest that the widespread ART administration among HIV-positive individuals is the best option for improving individual health outcomes and eliminating the risk of transmission.
Continue reading
The latest numbers pertaining to HIV infections in Singapore are consistent with international findings. For several years in a row, the rate of new infections has been declining. In fact, the 2022 figure has been the lowest one since 1998.
Continue reading
Blue waffle disease was first mentioned online in 2010 and ever since, conversations about the new STD have been ongoing. Many people are wondering whether this one is a real condition or just an online hoax. Reviewing the available information and consulting medical professionals reveals the answer to this question.
Continue reading
Scientists have long been working on the development of an effective and broad HIV vaccine. A new nanoparticle HIV vaccine candidate seems to be overcoming challenges that previous developments couldn’t address. The candidate helps for the development of antibodies that can neutralise about 90 per cent of HIV strains.
Continue reading
While modern antiretroviral therapies can suppress the human immunodeficiency virus to nearly undetectable levels, there is still no cure for the infection. Cornell researchers have currently received a grant that will allow examination of important cellular mechanisms standing in the way of eliminating the infection. This new research increases the hope of finding a cure.
Continue reading
It’s a well-known fact that HIV affects men disproportionately. The latest annual statistics from the US suggest that high risk groups like men who have sex with men are benefiting from reliable protection in the form of HIV PrEP. PrEP has contributed to a significant slowdown in the number of new infections and the trend has been ongoing ever since 2017.
Continue reading
Research from the US suggests that a new “super” strain of gonorrhoea has already started infecting individual. This strain is resistant to nearly every class of antibiotic used for the treatment of the STD. the situation is considered a public health crisis that necessitates the development of a brand new therapeutic approach.
Continue reading